Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Pre-eclampsia was reduced consistently with LDC with or without co-supplements (nine trials, 2234 women, relative risk [RR] 0.38; 95% confidence interval [95% CI] 0.28 to 0.52), as well as for subgroups: LDC alone (four trials, 980 women, RR 0.36; 95% CI 0.23 to 0.57]); LDC plus linoleic acid (two trials, 134 women, RR 0.23; 95% CI 0.09 to 0.60); LDC plus vitamin D (two trials, 1060 women, RR 0.49; 0.31 to 0.78) and a trend for LDC plus antioxidants (one trial, 60 women, RR 0.24; 95% CI 0.06 to 1.01).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary

Systematic review · Bjog · 2014

Original publication title

Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary

GJ Hofmeyr; JM Belizán; P von Dadelszen

©2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.

Original publication · Publisher record · CC BY 3.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These limited data are consistent with LDC reducing the risk of pre-eclampsia; confirming this in sufficiently powered randomised controlled trials would have implications for current guidelines and their global implementation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To review the impact of lower dose calcium supplementation on pre-eclampsia risk.

Source: Objectives

Abstract: Search strategy and selection criteria

We searched PubMed and the Cochrane Pregnancy and Childbirth Group trials register.

Source: Search strategy and selection criteria

Abstract: Data collection and analysis

Two authors extracted data from eligible randomised and quasi-randomised trials of low-dose calcium (LDC, <1 g/day), with or without other supplements.

Source: Data collection and analysis

Abstract: Main results

Pre-eclampsia was reduced consistently with LDC with or without co-supplements (nine trials, 2234 women, relative risk [RR] 0.38; 95% confidence interval [95% CI] 0.28 to 0.52), as well as for subgroups: LDC alone (four trials, 980 women, RR 0.36; 95% CI 0.23 to 0.57]); LDC plus linoleic acid (two trials, 134 women, RR 0.23; 95% CI 0.09 to 0.60); LDC plus vitamin D (two trials, 1060 women, RR 0.49; 0.31 to 0.78) and a trend for LDC plus antioxidants (one trial, 60 women, RR 0.24; 95% CI 0.06 to 1.01).

Overall results were consistent with the single quality trial of LDC alone (171 women, RR 0.30; 95% CI 0.06 to 1.38). LDC plus antioxidants commencing at 8 to 12 weeks tended to reduce miscarriage (one trial, 60 women, RR 0.06; 95% CI 0.00 to 1.04).

Source: Main results

Abstract: Conclusions

These limited data are consistent with LDC reducing the risk of pre-eclampsia; confirming this in sufficiently powered randomised controlled trials would have implications for current guidelines and their global implementation.

Source: Conclusions
Authors’ abstract

Background

Epidemiological data link low dietary calcium with pre-eclampsia. Current recommendations are for 1.5 to 2 g/day calcium supplementation for low-intake pregnant women, based on randomised controlled trials of ≥1 g/day calcium supplementation from 20 weeks of gestation. This is problematic logistically in low-resource settings; excessive calcium may be harmful; and 20 weeks may be too late to alter outcomes.

Objectives

To review the impact of lower dose calcium supplementation on pre-eclampsia risk.

Search strategy and selection criteria

We searched PubMed and the Cochrane Pregnancy and Childbirth Group trials register.

Data collection and analysis

Two authors extracted data from eligible randomised and quasi-randomised trials of low-dose calcium (LDC, <1 g/day), with or without other supplements.

Main results

Pre-eclampsia was reduced consistently with LDC with or without co-supplements (nine trials, 2234 women, relative risk [RR] 0.38; 95% confidence interval [95% CI] 0.28 to 0.52), as well as for subgroups: LDC alone (four trials, 980 women, RR 0.36; 95% CI 0.23 to 0.57]); LDC plus linoleic acid (two trials, 134 women, RR 0.23; 95% CI 0.09 to 0.60); LDC plus vitamin D (two trials, 1060 women, RR 0.49; 0.31 to 0.78) and a trend for LDC plus antioxidants (one trial, 60 women, RR 0.24; 95% CI 0.06 to 1.01).

Overall results were consistent with the single quality trial of LDC alone (171 women, RR 0.30; 95% CI 0.06 to 1.38). LDC plus antioxidants commencing at 8 to 12 weeks tended to reduce miscarriage (one trial, 60 women, RR 0.06; 95% CI 0.00 to 1.04).

Conclusions

These limited data are consistent with LDC reducing the risk of pre-eclampsia; confirming this in sufficiently powered randomised controlled trials would have implications for current guidelines and their global implementation.

Publication and source details

Original title: Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary

GJ Hofmeyr; JM Belizán; P von Dadelszen

Bjog · 2014

Correspondence: P von Dadelszen, Department of Obstetrics and Gynaecology and Child and Family Research Institute, University of British Columbia, Room V3-339, 950 West 28th Avenue, Vancouver, BC V5Z 4H4, Canada. Email pvd@cw.bc.ca
*

Including Bergel E, Cormick G, Hall DR, Fawcus S, Lazaga Betran AP, Munjanja S, Novikova N, Oyebajo A, Purnat T, Roberts JM, Sawchuck D and Singata M.

©2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.2014https://creativecommons.org/licenses/by/3.0/This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T11:52:45.294588+00:00

DOI: 10.1111/1471-0528.12613 · PMC4282055